Literature DB >> 27326547

Racial/Ethnic and Socioeconomic Differences in Colorectal and Breast Cancer Treatment Quality: The Role of Physician-level Variations in Care.

Ioana Popescu1, Deborah Schrag, Alfonso Ang, Mitchell Wong.   

Abstract

BACKGROUND: Despite a large body of research showing racial/ethnic and socioeconomic disparities in cancer treatment quality, the relative role of physician-level variations in care is unclear.
OBJECTIVE: To examine the effect of physicians on disparities in breast and colorectal cancer care.
SUBJECTS: Linked SEER Medicare data were used to identify Medicare beneficiaries diagnosed with colorectal and breast cancer during 1995-2007 and their treating physicians. RESEARCH
DESIGN: We identified treating physicians from Medicare claims data. We measured the use of NIH guideline-recommended therapies from SEER and Medicare claims data, and used logistic models to examine the relationship between race/ethnicity, socioeconomic status, and cancer quality of care. We used physician fixed effects to account for between-physician variations in treatment.
RESULTS: Minority and low socioeconomic status beneficiaries with breast and colorectal cancer were less likely to receive any recommended treatments as compared with whites. Overall, between-physician variation explained <20% of the total variation in quality of care. After accounting for between-physician differences, median household income explained 14.3%, 18.4%, and 13.2% of the variation in use of breast-conserving surgery, chemotherapy, and radiation for breast cancer, and 13.7%, 12.9%, and 12.6% of the within-physician variation in use of colorectal surgery, chemotherapy, and radiation for colorectal cancer, whereas race and ethnicity explained <2% of the within-physician variation in cancer care.
CONCLUSIONS: Between-physician variations partially explain racial disparities in cancer care. Residual within-physician disparities may be due to differences in patient-provider communication, patient preferences and treatment adherence, or unmeasured clinical severity.

Entities:  

Mesh:

Year:  2016        PMID: 27326547      PMCID: PMC6173517          DOI: 10.1097/MLR.0000000000000561

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  43 in total

1.  Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality.

Authors:  Jennifer S Haas; Phyllis Brawarsky; Aarthi Iyer; Garrett M Fitzmaurice; Bridget A Neville; Craig Earle
Journal:  Cancer       Date:  2011-03-16       Impact factor: 6.860

2.  Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Authors:  D Schrag; L D Cramer; P B Bach; C B Begg
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

3.  The effect of race and sex on physicians' recommendations for cardiac catheterization.

Authors:  K A Schulman; J A Berlin; W Harless; J F Kerner; S Sistrunk; B J Gersh; R Dubé; C K Taleghani; J E Burke; S Williams; J M Eisenberg; J J Escarce
Journal:  N Engl J Med       Date:  1999-02-25       Impact factor: 91.245

4.  Racial variation in willingness to trade financial resources for life-prolonging cancer treatment.

Authors:  Michelle Y Martin; Maria Pisu; Robert A Oster; Julie M Urmie; Deborah Schrag; Haiden A Huskamp; Jeannette Lee; Catarina I Kiefe; Mona N Fouad
Journal:  Cancer       Date:  2011-04-26       Impact factor: 6.860

5.  Prior experiences of racial discrimination and racial differences in health care system distrust.

Authors:  Katrina Armstrong; Mary Putt; Chanita H Halbert; David Grande; Jerome Sanford Schwartz; Kaijun Liao; Noora Marcus; Mirar B Demeter; Judy A Shea
Journal:  Med Care       Date:  2013-02       Impact factor: 2.983

6.  Physician performance and racial disparities in diabetes mellitus care.

Authors:  Thomas D Sequist; Garrett M Fitzmaurice; Richard Marshall; Shimon Shaykevich; Dana Gelb Safran; John Z Ayanian
Journal:  Arch Intern Med       Date:  2008-06-09

7.  Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.

Authors:  Jennifer J Griggs; Sarah T Hawley; John J Graff; Ann S Hamilton; Reshma Jagsi; Nancy K Janz; Mahasin S Mujahid; Christopher R Friese; Barbara Salem; Paul H Abrahamse; Steven J Katz
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

8.  The role of black and Hispanic physicians in providing health care for underserved populations.

Authors:  M Komaromy; K Grumbach; M Drake; K Vranizan; N Lurie; D Keane; A B Bindman
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

Review 9.  Adjuvant therapy of colon cancer: current status and future directions.

Authors:  Ki Young Chung; Leonard B Saltz
Journal:  Cancer J       Date:  2007 May-Jun       Impact factor: 3.360

10.  Point: Treating stage II colon cancer: the quest for personalized adjuvant care.

Authors:  Maxwell T Vergo; Al B Benson
Journal:  J Natl Compr Canc Netw       Date:  2012-11-01       Impact factor: 11.908

View more
  14 in total

1.  Decision-making and socioeconomic disparities in colonoscopy screening in African Americans.

Authors:  Marc T Kiviniemi; Lynne B Klasko-Foster; Deborah O Erwin; Lina Jandorf
Journal:  Health Psychol       Date:  2018-03-29       Impact factor: 4.267

Review 2.  Surgical Services for Breast Cancer Patients in Australia, is There a Gap for Aboriginal and/or Torres Strait Islander Women?

Authors:  Elzerie de Jager; Ronny Gunnarsson; Yik-Hong Ho
Journal:  World J Surg       Date:  2021-09-23       Impact factor: 3.352

3.  First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based study.

Authors:  Angie Mae Rodday; Theresa Hahn; Anita J Kumar; Peter K Lindenauer; Jonathan W Friedberg; Andrew M Evens; Susan K Parsons
Journal:  Br J Haematol       Date:  2020-02-23       Impact factor: 6.998

4.  Evaluating Surveillance Patterns after Chemoradiation-Only Compared with Conventional Management for Older Patients with Rectal Cancer.

Authors:  C Tyler Ellis; Ashley L Cole; Hanna K Sanoff; Sharon Hinton; Stacie B Dusetzina; Karyn B Stitzenberg
Journal:  J Am Coll Surg       Date:  2019-01-25       Impact factor: 6.113

5.  Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.

Authors:  Traci LeMasters; S Suresh Madhavan; Usha Sambamoorthi; Hannah W Hazard-Jenkins; Kimberly M Kelly; Dustin Long
Journal:  J Natl Compr Canc Netw       Date:  2018-06       Impact factor: 11.908

6.  Interventional Cultural and Language Assistance Program: Associations between Cultural and Linguistic Factors and Satisfaction with Cancer Care.

Authors:  R Costas-Muniz; J Amir; M Paris; D Spratt; J Arevalo-Perez; S Fareedy; C J González; F Gany; M Camacho-Rivera; J R Osborne
Journal:  J Community Med Health Educ       Date:  2017-02-20

7.  Are There Disparities in Surgical Treatment for Breast Cancer Patients with Prior Physical Disability A Path Analysis.

Authors:  Lena Ansmann; Alfred Schabmann; Sophie Elisabeth Gross; Anke Gross-Kunkel; Ute-Susann Albert; Igor Osipov
Journal:  Breast Care (Basel)       Date:  2019-10-14       Impact factor: 2.860

8.  Disentangling Racial, Ethnic, and Socioeconomic Disparities in Treatment for Colorectal Cancer.

Authors:  Chelsea A Obrochta; James D Murphy; Ming-Hsiang Tsou; Caroline A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-06-09       Impact factor: 4.254

9.  Applying Latent Class Analysis on Cancer Registry Data to Identify and Compare Health Disparity Profiles in Colorectal Cancer Surgical Treatment Delay.

Authors:  Francisco A Montiel Ishino; Emmanuel A Odame; Kevin Villalobos; Martin Whiteside; Hadii Mamudu; Faustine Williams
Journal:  J Public Health Manag Pract       Date:  2022 Mar-Apr 01

10.  Determinants of Guideline-Discordant Breast Cancer Care.

Authors:  Jean A McDougall; Linda S Cook; Mei-Tzu C Tang; Hannah M Linden; Beti Thompson; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-22       Impact factor: 4.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.